Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2019 1
2020 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
[Individualized infliximab therapy: pharmacokinetic monitoring].
Santacana-Juncosa E, Padullés-Zamora A, Colom Codina H, Rodríguez-Alonso L, Guardiola-Capon J, Padullés-Zamora N. Santacana-Juncosa E, et al. Among authors: colom codina h. Farm Hosp. 2015 Jan 1;39(1):59-60. doi: 10.7399/fh.2015.39.1.7791. Farm Hosp. 2015. PMID: 25680435 Free article. Spanish. No abstract available.
Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.
Santacana Juncosa E, Rodríguez-Alonso L, Padullés Zamora A, Guardiola J, Rodríguez-Moranta F, Serra Nilsson K, Bas Minguet J, Morandeira Rego F, Colom Codina H, Padullés Zamora N. Santacana Juncosa E, et al. Among authors: colom codina h. Br J Clin Pharmacol. 2021 Feb;87(2):494-505. doi: 10.1111/bcp.14410. Epub 2020 Jun 26. Br J Clin Pharmacol. 2021. PMID: 32495380 Free article.
Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?
Esteve-Pitarch E, Gumucio-Sanguino VD, Cobo-Sacristán S, Shaw E, Maisterra-Santos K, Sabater-Riera J, Pérez-Fernandez XL, Rigo-Bonnin R, Tubau-Quintano F, Carratalà J, Colom-Codina H, Padullés-Zamora A. Esteve-Pitarch E, et al. Among authors: colom codina h. Eur J Drug Metab Pharmacokinet. 2021 Jul;46(4):527-538. doi: 10.1007/s13318-021-00694-0. Epub 2021 Jun 15. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34131869
Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
Martínez-Casanova J, Esteve-Pitarch E, Colom-Codina H, Gumucio-Sanguino VD, Cobo-Sacristán S, Shaw E, Maisterra-Santos K, Sabater-Riera J, Pérez-Fernandez XL, Rigo-Bonnin R, Tubau-Quintano F, Carratalà J, Padullés-Zamora A. Martínez-Casanova J, et al. Among authors: colom codina h. Antibiotics (Basel). 2023 Mar 7;12(3):531. doi: 10.3390/antibiotics12030531. Antibiotics (Basel). 2023. PMID: 36978398 Free PMC article.
Semimechanistic model to characterize nonlinear pharmacokinetics of nimotuzumab in patients with advanced breast cancer.
Rodríguez-Vera L, Ramos-Suzarte M, Fernández-Sánchez E, Soriano JL, Guitart CP, Hernández GC, Jacobo-Cabral CO, de Castro Suárez N, Codina HC. Rodríguez-Vera L, et al. Among authors: codina hc. J Clin Pharmacol. 2015 Aug;55(8):888-98. doi: 10.1002/jcph.496. Epub 2015 Apr 24. J Clin Pharmacol. 2015. PMID: 25760761 Clinical Trial.